New SARS-CoV-2 neutralizing antibody enters clinical phase
Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a ...
Dec 18, 2020
0
3